Literature DB >> 24141905

No difference in in vivo polyethylene wear particles between oxidized zirconium and cobalt-chromium femoral component in total knee arthroplasty.

Yukihide Minoda1, Kanako Hata, Hiroyoshi Iwaki, Mitsuhiko Ikebuchi, Yusuke Hashimoto, Fumiaki Inori, Hiroaki Nakamura.   

Abstract

PURPOSE: Polyethylene wear particle generation is one of the most important factors affecting mid- to long-term results of total knee arthroplasties. Oxidized zirconium was introduced as a material for femoral components to reduce polyethylene wear generation. However, an in vivo advantage of oxidized zirconium on polyethylene wear particle generation is still controversial. The purpose of this study was to compare in vivo polyethylene wear particles between oxidized zirconium total knee prosthesis and conventional cobalt-chromium (Co-Cr) total knee prosthesis.
METHODS: Synovial fluid was obtained from the knees of 6 patients with oxidized zirconium total knee prosthesis and from 6 patients with conventional cobalt-chromium (Co-Cr) total knee prosthesis 12 months after the operation. Polyethylene particles were isolated and examined using a scanning electron microscope and image analyser.
RESULTS: Total number of particles in each knee was 3.3 ± 1.3 × 10(7) in the case of oxidized zirconium (mean ± SD) and 3.4 ± 1.2 × 10(7) in that of Co-Cr (n.s.). The particle size (equivalent circle diameter) was 0.8 ± 0.3 μm in the case of oxidized zirconium and 0.6 ± 0.1 μm in that of Co-Cr (n.s.). The particle shape (aspect ratio) was 1.4 ± 0.0 in the case of oxidized zirconium and 1.4 ± 0.0 in that of metal Co-Cr (n.s).
CONCLUSIONS: Although newly introduced oxidized zirconium femoral component did not reduce the in vivo polyethylene wear particles in early clinical stage, there was no adverse effect of newly introduced material. At this moment, there is no need to abandon oxidized zirconium femoral component. However, further follow-up of polyethylene wear particle generation should be performed to confirm the advantage of the oxidized zirconium femoral component. LEVEL OF EVIDENCE: Therapeutic study, Level III.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24141905     DOI: 10.1007/s00167-013-2724-4

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  26 in total

1.  Diverse cellular and apoptotic responses to variant shapes of UHMWPE particles in a murine model of inflammation.

Authors:  Shang-You Yang; Weiping Ren; YoungSoo Park; Allison Sieving; Stephen Hsu; Sam Nasser; Paul H Wooley
Journal:  Biomaterials       Date:  2002-09       Impact factor: 12.479

2.  Matched-pair total knee arthroplasty retrieval analysis: oxidized zirconium vs. CoCrMo.

Authors:  Thomas J Heyse; Dan X Chen; Natalie Kelly; Friedrich Boettner; Timothy M Wright; Steven B Haas
Journal:  Knee       Date:  2010-09-24       Impact factor: 2.199

3.  Total knee replacement using the Genesis II prosthesis: a 5-year follow up study of the first 100 consecutive cases.

Authors:  Richard S Laskin; John Davis
Journal:  Knee       Date:  2005-06       Impact factor: 2.199

4.  The 5-year results of an oxidized zirconium femoral component for TKA.

Authors:  Massimo Innocenti; Roberto Civinini; Christian Carulli; Fabrizio Matassi; Marco Villano
Journal:  Clin Orthop Relat Res       Date:  2009-10-02       Impact factor: 4.176

5.  In vivo analysis of polyethylene wear particles after total knee arthroplasty: the influence of improved materials and designs.

Authors:  Yukihide Minoda; Akio Kobayashi; Hiroyoshi Iwaki; Kentarou Iwakiri; Fumiaki Inori; Ryo Sugama; Mitsuhiko Ikebuchi; Yoshinori Kadoya; Kunio Takaoka
Journal:  J Bone Joint Surg Am       Date:  2009-11       Impact factor: 5.284

6.  Polyethylene wear particle generation in vivo in an alumina medial pivot total knee prosthesis.

Authors:  Yukihide Minoda; Akio Kobayashi; Hiroyoshi Iwaki; Masatsugu Miyaguchi; Yoshinori Kadoya; Hirotsugu Ohashi; Kunio Takaoka
Journal:  Biomaterials       Date:  2005-10       Impact factor: 12.479

7.  Improved design decreases wear in total knee arthroplasty with varus malalignment.

Authors:  Kazutaka Nishikawa; Ken Okazaki; Shuichi Matsuda; Yasutaka Tashiro; Shinya Kawahara; Hiroyuki Nakahara; Shigetoshi Okamoto; Takeshi Shimoto; Hidehiko Higaki; Yukihide Iwamoto
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-04-16       Impact factor: 4.342

8.  Simulated knee wear with cobalt chromium and oxidized zirconium knee femoral components.

Authors:  S E White; L A Whiteside; D S McCarthy; M Anthony; R A Poggie
Journal:  Clin Orthop Relat Res       Date:  1994-12       Impact factor: 4.176

9.  In vivo comparison of wear particles between highly crosslinked polyethylene and conventional polyethylene in the same design of total knee arthroplasties.

Authors:  Kentaro Iwakiri; Yukihide Minoda; Akio Kobayashi; Ryo Sugama; Hiroyoshi Iwaki; Fumiaki Inori; Yusuke Hashimoto; Hirotsugu Ohashi; Yoichi Ohta; Kenji Fukunaga; Kunio Takaoka
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-11       Impact factor: 3.368

10.  Characteristics of polyethylene wear particles isolated from synovial fluid after mobile-bearing and posterior-stabilized total knee arthroplasties.

Authors:  Yukihide Minoda; Akio Kobayashi; Hiroyoshi Iwaki; Masatsugu Miyaguchi; Yoshinori Kadoya; Hirotsugu Ohashi; Kunio Takaoka
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2004-10-15       Impact factor: 3.368

View more
  2 in total

1.  The 2018 Mark Coventry, MD Award: Does a Ceramic Bearing Improve Pain, Function, Wear, or Survivorship of TKA in Patients Younger Than 55 Years of Age? A Randomized Trial.

Authors:  Young-Hoo Kim; Jang-Won Park; Jun-Shik Kim
Journal:  Clin Orthop Relat Res       Date:  2019-01       Impact factor: 4.176

2.  Comparison of in vivo polyethylene wear particles between mobile- and fixed-bearing TKA in the same patients.

Authors:  Yukihide Minoda; Kanako Hata; Mitsuhiko Ikebuchi; Shigekazu Mizokawa; Yoichi Ohta; Hiroaki Nakamura
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-02-04       Impact factor: 4.342

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.